KR20050009755A - 1-[(인돌-3-일)카르보닐]피페라진 유도체 - Google Patents

1-[(인돌-3-일)카르보닐]피페라진 유도체 Download PDF

Info

Publication number
KR20050009755A
KR20050009755A KR10-2004-7020734A KR20047020734A KR20050009755A KR 20050009755 A KR20050009755 A KR 20050009755A KR 20047020734 A KR20047020734 A KR 20047020734A KR 20050009755 A KR20050009755 A KR 20050009755A
Authority
KR
South Korea
Prior art keywords
carbonyl
indol
methoxy
cyclohexylmethyl
mmol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR10-2004-7020734A
Other languages
English (en)
Korean (ko)
Inventor
카우리필립마틴
콜필드윌슨
티어니제이슨
카인스제임스
아담-워럴줄리아
요크마크
Original Assignee
악조 노벨 엔.브이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 악조 노벨 엔.브이. filed Critical 악조 노벨 엔.브이.
Publication of KR20050009755A publication Critical patent/KR20050009755A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
KR10-2004-7020734A 2002-06-21 2003-06-13 1-[(인돌-3-일)카르보닐]피페라진 유도체 Ceased KR20050009755A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02077505 2002-06-21
EP02077505.2 2002-06-21
PCT/EP2003/050226 WO2004000832A1 (en) 2002-06-21 2003-06-13 1-[(indol-3-yl)carbonyl] piperazine derivatives

Publications (1)

Publication Number Publication Date
KR20050009755A true KR20050009755A (ko) 2005-01-25

Family

ID=29797228

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2004-7020734A Ceased KR20050009755A (ko) 2002-06-21 2003-06-13 1-[(인돌-3-일)카르보닐]피페라진 유도체

Country Status (32)

Country Link
US (1) US7304064B2 (cg-RX-API-DMAC7.html)
EP (1) EP1549637B1 (cg-RX-API-DMAC7.html)
JP (1) JP4408804B2 (cg-RX-API-DMAC7.html)
KR (1) KR20050009755A (cg-RX-API-DMAC7.html)
CN (1) CN1298716C (cg-RX-API-DMAC7.html)
AR (1) AR040274A1 (cg-RX-API-DMAC7.html)
AT (1) ATE361290T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003250245B2 (cg-RX-API-DMAC7.html)
BR (1) BR0311960A (cg-RX-API-DMAC7.html)
CA (1) CA2490141C (cg-RX-API-DMAC7.html)
CO (1) CO5680419A2 (cg-RX-API-DMAC7.html)
CY (1) CY1107677T1 (cg-RX-API-DMAC7.html)
DE (1) DE60313640T2 (cg-RX-API-DMAC7.html)
DK (1) DK1549637T3 (cg-RX-API-DMAC7.html)
EC (1) ECSP045503A (cg-RX-API-DMAC7.html)
ES (1) ES2285183T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20041186A2 (cg-RX-API-DMAC7.html)
IL (1) IL165572A0 (cg-RX-API-DMAC7.html)
IS (1) IS2443B (cg-RX-API-DMAC7.html)
MX (1) MXPA04012856A (cg-RX-API-DMAC7.html)
NO (1) NO20045351L (cg-RX-API-DMAC7.html)
NZ (1) NZ537143A (cg-RX-API-DMAC7.html)
PE (1) PE20040578A1 (cg-RX-API-DMAC7.html)
PL (1) PL375152A1 (cg-RX-API-DMAC7.html)
PT (1) PT1549637E (cg-RX-API-DMAC7.html)
RS (1) RS111104A (cg-RX-API-DMAC7.html)
RU (1) RU2318821C2 (cg-RX-API-DMAC7.html)
SI (1) SI1549637T1 (cg-RX-API-DMAC7.html)
TW (1) TW200402417A (cg-RX-API-DMAC7.html)
UA (1) UA78317C2 (cg-RX-API-DMAC7.html)
WO (1) WO2004000832A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200410057B (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI242015B (en) 1999-11-29 2005-10-21 Akzo Nobel Nv 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
ATE375349T1 (de) 2002-08-02 2007-10-15 Merck & Co Inc Substituierte furo(2,3-b)pyridin derivate
DE10253426B4 (de) 2002-11-15 2005-09-22 Elbion Ag Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phosphodiesterase 4 und Verfahren zu deren Herstellung
DE602004005893T2 (de) 2003-12-17 2007-09-06 N.V. Organon Trizyklische 1-((3-indol-3-yl)-carbonyl)-piperazin-derivate als cannabinoid-cb1-rezeptoragonisten
TWI330635B (en) * 2004-03-05 2010-09-21 Organon Nv (indol-3-yl)-heterocycle derivatives
US20090029984A1 (en) * 2005-07-11 2009-01-29 N.V. Organon Synergistic combination for the treatment of pain (cannabinoid receptor agonist and opioid receptor agonist)
CN102295636A (zh) * 2005-07-29 2011-12-28 弗·哈夫曼-拉罗切有限公司 吲哚-3-基-羰基-哌啶和哌嗪衍生物
TW200745096A (en) * 2005-08-23 2007-12-16 Organon Nv Indole derivatives
US7763732B2 (en) 2005-08-24 2010-07-27 N.V. Organon Indole derivatives
CA2623525A1 (en) * 2005-09-23 2007-04-05 Janssen Pharmaceutica N.V. Tetrahydro-indazolyl cannabinoid modulators
TW200848417A (en) 2007-02-22 2008-12-16 Organon Nv Indole derivatives
RU2387642C2 (ru) 2007-10-31 2010-04-27 Общество С Ограниченной Ответственностью "Бинатех" Производные 5-замещенных индол-3-карбоновой кислоты, обладающие противовирусной активностью, способ их получения и применение
GB201106817D0 (en) * 2011-04-21 2011-06-01 Astex Therapeutics Ltd New compound
CN115368356B (zh) 2013-12-20 2025-05-09 阿斯特克斯治疗有限公司 双环杂环化合物及其治疗用途
EP3737680A1 (en) 2018-01-08 2020-11-18 F. Hoffmann-La Roche AG Octahydropyrido[1,2-alpha]pyrazines as magl inhibitors
CN108752342A (zh) * 2018-08-17 2018-11-06 西安瑞联新材料股份有限公司 1-H-吡啶并[1,2-a]-6-氢吡嗪-1,4-二酮的制备方法
CN111100063B (zh) * 2018-10-25 2022-05-17 南京药石科技股份有限公司 一种合成2-氟甲基取代的吡咯烷、哌啶以及哌嗪衍生物的制备方法
CN114072405A (zh) 2019-07-03 2022-02-18 豪夫迈·罗氏有限公司 杂环单酰基甘油脂肪酶(magl)抑制剂
KR20220034104A (ko) 2019-07-09 2022-03-17 에프. 호프만-라 로슈 아게 신규 헤테로고리 화합물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9203454A (es) * 1989-12-28 1992-08-01 Upjohn Co Compuestos anti sida diaromaticos substituidos.
WO1998006715A1 (en) 1996-08-09 1998-02-19 Smithkline Beecham Corporation Novel piperazine containing compounds
AU1887401A (en) * 1999-12-14 2001-06-25 Nippon Shinyaku Co. Ltd. Medicinal composition
JP2004502642A (ja) * 2000-02-11 2004-01-29 ブリストル−マイヤーズ スクイブ カンパニー カンナビノイドレセプターモジュレーター、それらの製造方法、および呼吸系および非呼吸系疾患の処置のためのカンナビノイドレセプターモジュレーターの使用

Also Published As

Publication number Publication date
IS7590A (is) 2004-12-09
BR0311960A (pt) 2005-03-22
AR040274A1 (es) 2005-03-23
IS2443B (is) 2008-11-15
AU2003250245B2 (en) 2008-07-03
PT1549637E (pt) 2007-05-31
DK1549637T3 (da) 2007-07-16
PE20040578A1 (es) 2004-09-15
WO2004000832A1 (en) 2003-12-31
SI1549637T1 (sl) 2007-10-31
CN1298716C (zh) 2007-02-07
CO5680419A2 (es) 2006-09-29
DE60313640T2 (de) 2007-12-27
US20050250760A1 (en) 2005-11-10
JP4408804B2 (ja) 2010-02-03
RU2005101349A (ru) 2005-06-27
AU2003250245A1 (en) 2004-01-06
JP2005533801A (ja) 2005-11-10
RU2318821C2 (ru) 2008-03-10
CN1668611A (zh) 2005-09-14
DE60313640D1 (de) 2007-06-14
US7304064B2 (en) 2007-12-04
ZA200410057B (en) 2005-10-20
RS111104A (sr) 2007-02-05
CA2490141C (en) 2011-01-25
HRP20041186A2 (en) 2005-06-30
ES2285183T3 (es) 2007-11-16
ATE361290T1 (de) 2007-05-15
PL375152A1 (en) 2005-11-28
CA2490141A1 (en) 2003-12-31
IL165572A0 (en) 2006-01-15
MXPA04012856A (es) 2005-03-31
HK1076630A1 (en) 2006-01-20
TW200402417A (en) 2004-02-16
NZ537143A (en) 2005-05-27
ECSP045503A (es) 2005-03-10
EP1549637B1 (en) 2007-05-02
NO20045351L (no) 2005-01-20
EP1549637A1 (en) 2005-07-06
CY1107677T1 (el) 2013-04-18
UA78317C2 (en) 2007-03-15

Similar Documents

Publication Publication Date Title
JP4408804B2 (ja) 1−[(インドル−3−イル)カルボニル]ピペラジン誘導体
HRP20010854A2 (en) INDOLE-TYPE DERIVATIVES AS INHIBITORS OF p38 KINASE
JPH0649027A (ja) インドール誘導体
CN101484424A (zh) 治疗化合物
US5693655A (en) 3-indolylpiperidines
JP2004531506A (ja) 選択的なセロトニン再取り込みインヒビターとしてのシクロプロピルインドール誘導体
DE19730989A1 (de) Piperazin-Derivate
EP0330469A2 (en) Tetrahydroisoquinoline derivatives
KR20020067589A (ko) 페닐피페라지닐 유도체
JPS60215683A (ja) 新規縮合ジアゼピノン
CN116600808A (zh) 一类作为kras突变体g12c抑制剂的四氢萘啶类衍生物、其制备方法及其应用
EP2588458B1 (en) Novel tetrahydroquinoline derivatives
WO2024054866A2 (en) Heteroatom substituted cyclic and alkyl amines as activators of serotonin receptors
EP2137180B1 (en) Dibenzo [b,f][1,4] oxazapine compounds
RU2284325C2 (ru) Производные фенил-3-аминометил-хинолона-2 в качестве ингибиторов no-синтетазы, способ их получения, биологически активные соединения и фармацевтическая композиция на их основе
Tsotinis et al. Design, synthesis and melatoninergic activity of new unsubstituted and β, β′-difunctionalised 2, 3-dihydro-1H-pyrrolo [3, 2, 1-ij] quinolin-6-alkanamides
CN114591327A (zh) 吲哚啉哌啶脲类trpv1拮抗和mor激动双靶点药物及制备方法和应用
JPH0660172B2 (ja) 縮合したジアゼピノン類、それらの製造法及びこれらの化合物を含有する医薬組成物
HU226674B1 (en) Izoindeindolone compounds, process for their preparation and pharmaceutical compositions containing them
JPH0759580B2 (ja) 5,6,7,8―テトラヒドロ―β―カルボリン誘導体及びその製法
HK1076630B (en) 1-(indol-3-yl) carbonyl piperazine derivatives
CA2476490C (en) Indole derivatives substituted with long-chain alcohols and medicaments containing them
JPS60214784A (ja) 複素環式化合物
KR20050023401A (ko) 무스카린 수용체 길항제로서 사용가능한 3,6-이치환된아자비시클로 [3.1.0]헥산 유도체
KR20060014373A (ko) 무스카린 수용체 길항제로서의 치환된 아자비시클로 헥산유도체

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20041220

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20070227

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20080414

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20100517

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20100903

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20100517

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I